ArticleJournal of the Society for Cardiovascular Angiography & Interventions2025
Impact of Nitroglycerin Administration on Acetylcholine Provocation Testing in Angina With Nonobstructive Coronary Arteries.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Radial Access Strategies: Focus on Coronary Function Testing for Angina With Nonobstructive Coronary Arteries.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
- The Contemporary Role of Intracoronary Physiological Assessment: Fractional Flow Reserve, Non-Hyperemic Pressure Ratios, Wireless Technologies, and Microcirculation.Journal of cardiovascular development and disease · 2026Review
- Hold the Nitro: Acetylcholine Provocation Testing for Coronary Vasospasm.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Invasive coronary function testing, using acetylcholine (ACh) to diagnose coronary artery spasm (CAS) and coronary microvascular dysfunction assessment, is considered the gold standard for evaluating patients suffering from angina with nonobstructive coronary arteries. Notably, equipoise remains regarding the optimal sequence for coronary function testing, and no global consensus exists. Although nitroglycerin (NTG) is routinely administered post-radial access and prior to coronary microvascular dysfunction testing, its effect on subsequent ACh testing remains unclear. This study aimed to evaluate the diagnostic impact of preceding intravascular NTG on ACh provocation testing. Methods: Multivessel ACh provocation testing was systematically performed in patients with suspected CAS. To assess the reinducibility of epicardial spasm, an ACh rechallenge was performed in patients who tested positive by readministering the spasm provocation dose into the affected coronary artery at different time intervals following the administration of intravascular NTG. Results: This multicenter study enrolled 102 patients (mean age 59.3 ± 10.0 years; 55% female), of whom 40 were diagnosed with epicardial CAS and underwent ACh rechallenge. Among these, 25 patients (62.5%) exhibited a diffuse spasm pattern, whereas 15 patients (37.5%) demonstrated focal spasm. After the ACh rechallenge, epicardial spasm was reinduced in 22 patients (55%), microvascular spasm in 6 patients (15%), and no spasm in 12 patients (30%). The sensitivity of ACh provocation testing declined to 55% at the end of the rechallenge. Conclusions: Nitroglycerin administration reduces the diagnostic accuracy of ACh provocation testing for CAS in angina with nonobstructive coronary arteries patients. Findings from this study indicate that clinicians should avoid NTG administration prior to ACh testing or significantly delay ACh testing after NTG exposure to preserve diagnostic sensitivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.